Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Inhibition of Topors Ubiquitin Ligase Augments the Efficacy of DNA Hypomethylating Agents through DNMT1 Stabilization

Satoshi Kaito, Kazumasa Aoyama, Motohiko Oshima, Karl Agger, Kristian Helin, Yasuhito Nannya, Seishi Ogawa, Atsuya Nishiyama, Makoto Nakanishi, Atsushi Iwama

Blood (2023) 142 (Supplement 1): 414.

https://doi.org/10.1182/blood-2023-179684

Published: 2023

Journal Articles

Characterization of Multiple Myeloma Subpopulations Associated with Treatment Resistance By Single-Cell RNA Sequencing

Takahiro Kamiya, Motohiko Oshima, Shuhei Koide, Yaeko Nakajima-Takagi, Kazumasa Aoyama, Satoshi Kaito, Naoki Itokawa, Masayuki Yamashita, Noriko Doki, Keisuke Kataoka, Atsushi Iwama

Blood (2023) 142 (Supplement 1): 331.

https://doi.org/10.1182/blood-2023-179185

Published: 2023

Journal Articles

Exhausted T Cells Characterized By Upregulation of Specific Transcription Factors Are Increased in a Mouse Model of De Novo Mature B Cell Neoplasms

Blood (2022) 140 (Supplement 1): 4240–4241.

https://doi.org/10.1182/blood-2022-158111

Published: 2022

Journal Articles

Unraveling the Heterogeneity of Multiple Myeloma Cells By Single-Cell RNA Sequencing Analysis

Takahiro Kamiya, Motohiko Oshima, Shuhei Koide, Yaeko Nakajima-Takagi, Kazumasa Aoyama, Naoki Itokawa, Masayuki Yamashita, Noriko Doki, Keisuke Kataoka, Atsushi Iwama

Blood (2022) 140 (Supplement 1): 9939–9940.

https://doi.org/10.1182/blood-2022-166085

Published: 2022

Journal Articles

Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome

Shiro Tara, Yusuke Isshiki, Yaeko Nakajima-Takagi, Motohiko Oshima, Kazumasa Aoyama, Tomoyuki Tanaka, Daisuke Shinoda, Shuhei Koide, Atsunori Saraya, Satoru Miyagi, Ichiro Manabe, Hirotaka Matsui, Haruhiko Koseki, Vivian J. Bardwell, Atsushi Iwama

Blood (2018) 132 (23): 2470–2483.

https://doi.org/10.1182/blood-2018-01-827964

Published: 2018

Includes: Supplemental data

Journal Articles

Role of KDM2B and Non-Canonical PRC1.1 As a Tumor Suppressor in T-ALL

Yusuke Isshiki, MD, Yaeko Nakajima-Takagi, PhD, Motohiko Oshima, PhD, Kazumasa Aoyama, PhD, Atsunori Saraya, Emiko Sakaida, MD PhD, Chiaki Nakaseko, MD PhD, Koutaro Yokote, MD PhD, Haruhiko Koseki, PhD, Atsushi Iwama, MD PhD

Blood (2018) 132 (Supplement 1): 2597.

https://doi.org/10.1182/blood-2018-99-117831

Published: 2018

Journal Articles

Utx Insufficiency Cooperates with Braf V600E in the Induction of Myeloma in Mice

Ola Rizq, MD PhD, Naoya Mimura, MD PhD, Motohiko Oshima, PhD, Shuji Momose, MD PhD, Yaeko Nakajima-Takagi, PhD, Kazumasa Aoyama, PhD, Atsunori Saraya, Tohru Iseki, MD PhD, Emiko Sakaida, MD PhD, Chiaki Nakaseko, MDPhD, Yutaka Okuno, MD, PhD, Hiroaki Honda, MD PhD, Jun-ichi Tamaru, MDPhD, Atsushi Iwama, MD PhD

Blood (2018) 132 (Supplement 1): 1005.

https://doi.org/10.1182/blood-2018-99-114053

Published: 2018

Journal Articles

Molecular Mechanism behind the Synergistic Activity of Proteasome Inhibition and PRC2 Inhibition in the Treatment of Multiple Myeloma

Ola Rizq, MD, Naoya Mimura, MD PhD, Motohiko Oshima, PhD, Atsunori Saraya, Shuhei Koide, PhD, Yuko Kato, PhD, Kazumasa Aoyama, PhD, Yaeko Nakajima-Takagi, PhD, Changshan Wang, PhD, Anqi Ma, Jian Jin, PhD, Tohru Iseki, MD PhD, Chiaki Nakaseko, MD, PhD, Atsushi Iwama, MD PhD

Blood (2016) 128 (22): 312.

https://doi.org/10.1182/blood.V128.22.312.312

Published: 2016

Journal Articles

Role of the Polycomb Methyltransferase Ezh1 in Myelodysplastic Syndrome Induced By Ezh2 Insufficiency

Kazumasa Aoyama, PhD, Makiko Mochizuki-Kashio, PhD, Motohiko Oshima, PhD, Shuhei Koide, PhD, Yaeko Nakajima-Takagi, PhD, Mitsutaka Maeda, Goro Sashida, MD PhD, Atsushi Iwama, MD PhD

Blood (2016) 128 (22): 1968.

https://doi.org/10.1182/blood.V128.22.1968.1968

Published: 2016

Journal Articles

Distinctive Genetic Features of Plasma Cells in POEMS Syndrome

Blood (2016) 128 (22): 4404.

https://doi.org/10.1182/blood.V128.22.4404.4404

Published: 2016

Journal Articles

Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes

Shuhei Koide, Motohiko Oshima, Keiyo Takubo, Satoshi Yamazaki, Eriko Nitta, Atsunori Saraya, Kazumasa Aoyama, Yuko Kato, Satoru Miyagi, Yaeko Nakajima-Takagi, Tetsuhiro Chiba, Hirotaka Matsui, Fumio Arai, Yutaka Suzuki, Hiroshi Kimura, Hiromitsu Nakauchi, Toshio Suda, Yoichi Shinkai, Atsushi Iwama

Blood (2016) 128 (5): 638–649.

https://doi.org/10.1182/blood-2016-01-694810

Published: 2016

Includes: Supplemental data

Journal Articles

Novel Leukemia Stem Cell-Targeted Therapy for Acute Myeloid Leukemia Based on Dual Inhibition of Ezh1/Ezh2

Shuhei Fujita, MD BS, Daisuke Honma, PhD, Nobuaki Adachi, PhD, Kazushi Araki, D.V.M., PhD, Emi Takamatsu, PhD, Kazumasa Aoyama, PhD, Atsushi Iwama, MD PhD, Issay Kitabayashi, PhD

Blood (2015) 126 (23): 457.

https://doi.org/10.1182/blood.V126.23.457.457

Published: 2015

Journal Articles

Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner

Makiko Mochizuki-Kashio, Kazumasa Aoyama, Goro Sashida, Motohiko Oshima, Takahisa Tomioka, Tomoya Muto, Changshan Wang, Atsushi Iwama

Blood (2015) 126 (10): 1172–1183.

https://doi.org/10.1182/blood-2015-03-634428

Published: 2015

Includes: Supplemental data

Journal Articles

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

Blood (2015) 125 (2): 304–315.

https://doi.org/10.1182/blood-2014-04-555508

Published: 2015

Includes: Supplemental data

NARROW

Inhibition of Topors Ubiquitin Ligase Augments the Efficacy of DNA Hypomethylating Agents through DNMT1 Stabilization

Characterization of Multiple Myeloma Subpopulations Associated with Treatment Resistance By Single-Cell RNA Sequencing

Exhausted T Cells Characterized By Upregulation of Specific Transcription Factors Are Increased in a Mouse Model of De Novo Mature B Cell Neoplasms

Unraveling the Heterogeneity of Multiple Myeloma Cells By Single-Cell RNA Sequencing Analysis

Bcor insufficiency promotes initiation and progression of myelodysplastic syndrome

Role of KDM2B and Non-Canonical PRC1.1 As a Tumor Suppressor in T-ALL

Utx Insufficiency Cooperates with Braf V600E in the Induction of Myeloma in Mice

Molecular Mechanism behind the Synergistic Activity of Proteasome Inhibition and PRC2 Inhibition in the Treatment of Multiple Myeloma

Role of the Polycomb Methyltransferase Ezh1 in Myelodysplastic Syndrome Induced By Ezh2 Insufficiency

Distinctive Genetic Features of Plasma Cells in POEMS Syndrome

Setdb1 maintains hematopoietic stem and progenitor cells by restricting the ectopic activation of nonhematopoietic genes

Novel Leukemia Stem Cell-Targeted Therapy for Acute Myeloid Leukemia Based on Dual Inhibition of Ezh1/Ezh2

Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner

Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only